CLOMID

This brand name is authorized in Australia, Brazil, Estonia, France, Ireland, Japan, Malta, Netherlands, United Kingdom

Active ingredients

The drug CLOMID contains one active pharmaceutical ingredient (API):

1 Clomifene UNII 1B8447E7YI - CLOMIPHENE CITRATE

Clomifene is a non-steroidal agent which stimulates ovulation in a high percentage of appropriately selected anovulatory women. The ovulatory response to clomifene therapy is mediated through increased output of pituitary gonadotrophins, which in turn stimulates the maturation and endocrine activity of the ovarian follicle. Read about Clomifene

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CLOMID Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03GB02	Clomifene	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GB Ovulation stimulants, synthetic
Discover more medicines within G03GB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1211R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525003101115414
Country: EE	Ravimiamet	Identifier(s): 1753073
Country: FR	Base de données publique des médicaments	Identifier(s): 65338028
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 196927, 23764
Country: IE	Health Products Regulatory Authority	Identifier(s): 17833
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499009F1080
Country: MT	Medicines Authority	Identifier(s): AA1228/00901, AA770/03802
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 1538